Trials in Los Angeles, California
Here are the top 10 medical studies for prostate cancer in Los Angeles, California
Popular Filters
Phase 3 Trials
Radioisotope Therapy
177Lu-PSMA-I&T for Prostate Cancer
Recruiting2 awardsPhase 3
Santa Monica, California
This trial is testing a new radioactive drug against standard hormone therapy in men with advanced prostate cancer that doesn't respond to usual treatments. The drug targets and kills cancer cells using radiation. The drug being tested, 225Ac-PSMA-617, has shown promise in inducing complete responses in patients with metastatic castrate-resistant prostate cancer who were resistant to standard therapies.
Taxane
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Beverly Hills, California
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Radiation
Shorter vs Usual Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Los Angeles, California
This trial is comparing two different types of radiation therapy for high-risk prostate cancer. One type, called stereotactic body radiation therapy (SBRT), involves giving higher doses of radiation over a shorter period
Trials With No Placebo
Monoclonal Antibodies
NGM831 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing a new drug called NGM831 alone or with other drugs in patients with advanced or spreading solid tumors. The goal is to see if these treatments can help stop the cancer or help the immune system fight it better. One of the drugs being tested has been widely studied and used in various cancers, showing significant improvements in survival rates and being effective in combination with other treatments.
Radioisotope Therapy
177Lu-PSMA-I&T for Prostate Cancer
Recruiting2 awardsPhase 3
Santa Monica, California
This trial is testing a new radioactive drug against standard hormone therapy in men with advanced prostate cancer that doesn't respond to usual treatments. The drug targets and kills cancer cells using radiation. The drug being tested, 225Ac-PSMA-617, has shown promise in inducing complete responses in patients with metastatic castrate-resistant prostate cancer who were resistant to standard therapies.
Behavioural Intervention
Physical Activity Intervention for Breast Cancer Survivors
Recruiting1 award7 criteria
Duarte, California
This trial uses a game-like system with social support to help Black or Hispanic breast and prostate cancer survivors increase their physical activity. Participants wear a Fitbit to track their steps and set personal goals, making exercise more fun and motivating. Fitbit devices have been widely used in various studies to promote physical activity among cancer survivors.
Imaging Agent
PSMA-PET/CT Guided Biopsy for Prostate Cancer
Recruiting1 awardPhase < 1
Los Angeles, California
This trial is testing a new way to do a prostate biopsy, using a PSMA protein found on prostate cancer cells. The new biopsy is done with a PET/CT scan and may help improve the detection rate of prostate cancer.
Behavioral Intervention
Virtual Group-Based Physical Activity for Cancer Survivors
Recruiting1 award8 criteria
Los Angeles, California
This trial will test whether group-based physical activity, delivered virtually, is feasible for AYA cancer survivors who have completed treatment. 20 participants will be enrolled for 3 months.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.